Chronic pain

Akston Biosciences' AKS-107 Study Published in Frontiers in Immunology, Displaying Ambifect® Platform’s Versatility

Retrieved on: 
Monday, March 11, 2024
Biotechnology, Manufacturing, Diabetes, Health, Pharmaceutical, Research, Other Manufacturing, Infectious Diseases, Science, Veterinary, Clinical Trials, MERS, NOD, Atopic dermatitis, Insulin, Immune tolerance, CGMP, Epitope, Mouse, Immunoglobulin G, Chronic pain, Protein, Infection, Vaccination, Immune system, Nerve growth factor, Notifiable disease, Dengue fever, Vaccine

The study demonstrated AKS-107's potential to target and delete insulin-specific B cells, which are implicated in the development of Type 1 Diabetes (T1D).

Key Points: 
  • The study demonstrated AKS-107's potential to target and delete insulin-specific B cells, which are implicated in the development of Type 1 Diabetes (T1D).
  • AKS-107 is a human IgG1 Fc-fusion protein engineered to retain conformational insulin epitopes that bind to B cell receptors while preventing binding to the insulin metabolic receptor.
  • Regarding its Animal Health applications, Akston is partnered with Dechra Pharmaceuticals PLC to commercialize canine and feline ultra-long insulins.
  • Akston Biosciences Corporation is dedicated to accelerating the next revolution in Animal Health by inventing, developing, and manufacturing breakthrough protein therapeutics for veterinary use.

Nura Pain Clinics Welcomes Dr. Larry Studt as Patient Care Capabilities and Demand Continue to Grow

Retrieved on: 
Wednesday, April 3, 2024
Family, Patient, Chronic pain, Minneapolis–Saint Paul, Pain management, Pain, Physician, Occupational medicine, Singing, Nursing

EDINA, Minn., April 3, 2024 /PRNewswire/ -- Nura Pain Clinics, Minnesota's foremost multidisciplinary pain management clinic, announced today that Dr. Larry Studt will join their team of pain management providers this month.  

Key Points: 
  • EDINA, Minn., April 3, 2024 /PRNewswire/ -- Nura Pain Clinics , Minnesota's foremost multidisciplinary pain management clinic, announced today that Dr. Larry Studt will join their team of pain management providers this month.
  • Nura, a subsidiary of the Capitol Pain family of practices, is committed to delivering exceptional patient-centered care, especially as demands for their pain services continue to grow.
  • With the addition of Dr. Studt, Nura now has two full-time providers dedicated to seeing new patients.
  • For more information on Nura Pain Clinics and its focus on pain management, visit nuraclinics.com .

Universal Brain Expands Executive Team to Accelerate Precision Psychiatry

Retrieved on: 
Wednesday, April 3, 2024
Diagnosis, Depression, EEG, Mental health, Algorithm, Psychological Science, VR, Psychophysiology, Patient, American Psychological Association, Anxiety, Chronic pain, IEC, Society, PALO, Fortune 500, Santa Clara University, Enosis, ISO, FDA, Lisa Feldman Barrett, Medtech, Nursing

PALO ALTO, Calif., April 3, 2024 /PRNewswire/ -- Universal Brain, developer of a neuroscience-based personalized treatment and diagnostic platform pioneering precision psychiatry, today announced the expansion of its executive team. The company, which recently closed a $3.2 million seed round, will leverage the key additions to its executive team to accelerate the development and rollout of its comprehensive platform to aid the diagnosis and treatment of depression and other mental health conditions.

Key Points: 
  • PALO ALTO, Calif., April 3, 2024 /PRNewswire/ -- Universal Brain , developer of a neuroscience-based personalized treatment and diagnostic platform pioneering precision psychiatry, today announced the expansion of its executive team.
  • Universal Brain is developing the first and only platform to deliver objective, industry-defining measures to better understand and treat psychiatric conditions.
  • By objectively measuring profiles of brain function, Universal Brain will reduce heterogeneity to improve precision in identification and development of more personalized treatments.
  • "Their highly regarded expertise in their respective disciplines paired with a shared vision of advancing precision psychiatry through the use of objective data will be invaluable as we bring the Universal Brain platform to market."

Innovating "Treadmill Exercise Test AI-Assisted Interpretation System," CMUH(Taiwan) Timely Saves More Patients with Severe Myocardial Infarction

Retrieved on: 
Tuesday, April 2, 2024
Depression, Thrombosis, Myocardial infarction, Sudden death, Cardiovascular disease, Exercise, Survival, Coronary artery disease, ECG, Hyperlipidemia, Patient, Palpitations, Angina, Cancer, AI, Death, Moyamoya disease, Chronic pain, Plaque, Diet, Receiver, Smoking, Cardiac catheterization, Stenosis, Oxygen, Heart, Atherosclerosis, Rupture, Ministry, Duke, Vascular occlusion, CAD

To address this issue, China Medical University Hospital (CMUH) AI Center successfully developed the "Treadmill Exercise Test AI-Assisted Interpretation System" which was trained with nearly a thousand treadmill ECG, in patients with coronary arterystenosisover 70% shown on their coronary angiography.

Key Points: 
  • To address this issue, China Medical University Hospital (CMUH) AI Center successfully developed the "Treadmill Exercise Test AI-Assisted Interpretation System" which was trained with nearly a thousand treadmill ECG, in patients with coronary arterystenosisover 70% shown on their coronary angiography.
  • The program also utilizes ten measured features and two derived features including maximal work output and peak heart rate to determine the severity of coronary artery stenosis.
  • Generally, coronary heart disease in patients of middle or senior age is presented as angina or myocardial infarction and is one of the primary causes of sudden death."
  • Dr. Wu stated, "Coronary artery stenosis is a multi-factorial condition related to smoking, advanced age, diabetes hypertension and hyperlipidemia.

Innocan Pharma Reports Full Year 2023 Results with Revenues up Nearly 6X to $13.7M

Retrieved on: 
Monday, April 1, 2024
Sky Global, LPT, Gross income, Beauty, Patient, Operating cost, CBD, Bank statement, OTC, Chronic pain, FDA, Pharmaceutical industry

This significant increase in revenue was primarily due to the robust sales performance of Innocan's subsidiary, BI Sky Global Ltd.

Key Points: 
  • This significant increase in revenue was primarily due to the robust sales performance of Innocan's subsidiary, BI Sky Global Ltd.
  • Gross Profit increased 568% year-over-year to US$12.0 million for the year ended December 31, 2023, compared to US$2.1 million for 2022.
  • Iris Bincovich, the CEO of Innocan commented: "We are very pleased with our performance in 2023, closing the year with a strong fourth quarter.
  • Roni Kamhi, CEO BI Sky Global and COO of Innocan Pharma commented: "Our consumer wellness products are trusted by millions of customers.

Welltory Launches First Personalized AI-generated Bedtime Stories Driven by Users' Heartbeats

Retrieved on: 
Wednesday, March 27, 2024
Narration, Synthetic media, DMN, Relaxation, ASMR, Library, Heart rate, Insomnia, Sleep, Research, AI, Chronic pain, Wakefulness, Human, CDC, Default mode network, Oscillation, Emotion, PTSD

REDWOOD CITY, Calif., March 27, 2024 /PRNewswire/ -- A team of both humans and AI crafted Sleep Flow's endless library. While AI ensures infinite variety, humans play a crucial role in proofreading, infusing stories with emotional depth, and incorporating scientific techniques.

Key Points: 
  • REDWOOD CITY, Calif., March 27, 2024 /PRNewswire/ -- A team of both humans and AI crafted Sleep Flow's endless library.
  • While AI ensures infinite variety, humans play a crucial role in proofreading, infusing stories with emotional depth, and incorporating scientific techniques.
  • Jane Smorodnikova, Welltory's CEO and co-founder, said: "CDC reports that 14.5% of adults in the US have trouble falling asleep nearly every day.
  • That is why we decided that Sleep Flow should never end and constantly surprise users with something fresh and relaxing.

Empowering Wellness: PÜR LIFE Medical of Fishers Introduces Innovative Health Solutions

Retrieved on: 
Wednesday, March 27, 2024
Obesity, Exercise, Inflammation, Weight loss, Chronic pain, Quality of life, Arthritis, Hormone replacement therapy, Pain, Fatigue, Fisher

FISHERS, Ind., March 27, 2024 /PRNewswire/ -- PÜR LIFE Medical of Fishers is redefining the healthcare landscape with personalized healthcare services, tailored to individuals seeking holistic solutions to their health challenges.

Key Points: 
  • FISHERS, Ind., March 27, 2024 /PRNewswire/ -- PÜR LIFE Medical of Fishers is redefining the healthcare landscape with personalized healthcare services, tailored to individuals seeking holistic solutions to their health challenges.
  • PÜR LIFE's approach to hormone and gut health optimization involves a comprehensive evaluation of each patient's medical history, symptoms, and lifestyle factors.
  • At PÜR LIFE, the medical team specializes in comprehensive joint care, offering a range of treatment options to address pain, inflammation, and functional limitations.
  • For further details about PÜR LIFE Medical of Fishers and its services, please visit their website at purlifemedicalfishers.com .

Viewpoint with Dennis Quaid Partners with Kinotek® to Explore Technological Innovation in Musculoskeletal Health

Retrieved on: 
Wednesday, March 27, 2024
Health, Organization, Partnership, Knowledge, Musculoskeletal injury, 3D, Chronic pain, Quality of life, Human musculoskeletal system, Pain, Multimedia, MSK, Movement, Map, Television

MIAMI, March 27, 2024 /PRNewswire-PRWeb/ -- Viewpoint, the esteemed educational program hosted by actor Dennis Quaid, is thrilled to announce an upcoming collaboration with Kinotek for an episode dedicated to exploring technological innovation in musculoskeletal (MSK) health. This partnership underscores Viewpoint's commitment to providing viewers with informative and transformative content that highlights cutting-edge solutions to pressing health issues.

Key Points: 
  • The educational program looks into the health sector...
    MIAMI, March 27, 2024 /PRNewswire-PRWeb/ -- Viewpoint, the esteemed educational program hosted by actor Dennis Quaid, is thrilled to announce an upcoming collaboration with Kinotek for an episode dedicated to exploring technological innovation in musculoskeletal (MSK) health.
  • A representative of Viewpoint said, "We're excited to partner with Kinotek to explore the transformative potential of technology in musculoskeletal health.
  • As filming commences and preparations for distribution are underway, Viewpoint and Kinotek invite individuals and organizations to join the conversation and contribute to the ongoing dialogue surrounding musculoskeletal health and technological innovation.
  • Development Division, Viewpoint with host Dennis Quaid, 561-244-7620, [email protected] , www.viewpointproject.com
    View original content to download multimedia: https://www.prweb.com/releases/viewpoint-with-dennis-quaid-partners-with...

"The Yoga Therapy Renaissance" Sheds Light on an Increasingly Important Field

Retrieved on: 
Tuesday, March 26, 2024
Yoga as therapy, Health, Organization, Head, Yoga, Growth, Initiative, Exercise, Walking, Cardiology, Science, GWI, Education, Conditional sentence, International Association, Patient, Knowledge, Accreditation, Sleep, Research, T. K. V. Desikachar, Ebook, Chronic pain, Nature, Publication, Immunity, Meditation, Medicine, Evidence-based practice, Workplace, Fatigue, Abnormal psychology, Century, Loneliness, Rehabilitation, Health care

CHICAGO, March 26, 2024 /PRNewswire/ -- Yoga Therapy, an evidence-based practice used to treat chronic diseases, structural conditions and mental health issues, as well as foster wellbeing and personal growth, is taking root as a powerful tool to improve health and wellness, healing and more. However, it remains little understood by not only the public at large but also by healthcare professionals and many practitioners and teachers of more widespread forms of yoga. A new free eBook by Bija Bennett and industry experts, "The Yoga Therapy Renaissance: A New Wellness Modality for the 21st Century," covers the origins, evolution, growth, training programs, applications across industries and vast potential this distinct wellness modality has for modern healthcare.

Key Points: 
  • "Like yoga, a 5,000-year-old set of practices that has enjoyed exponential growth in the last decade, Yoga Therapy is an ancient modality that is flourishing once again," Bennett noted.
  • Yoga Therapy is a subset of yoga based on the therapeutic and clinical application of specific practices, but these therapeutic methods are now being incorporated into top healthcare systems' integrative medicine programs.
  • As a result, yoga therapists are increasingly earning the necessary certifications for this form of therapy and becoming engaged in clinical roles," Bennett, a certified yoga therapist, explained."
  • Her eBook, "The Yoga Therapy Renaissance," serves to:
    Validate Yoga Therapy's efficacy as a modern wellness modality and discipline built on a profound body of knowledge, experience and substantiated benefits;
    Differentiate Yoga Therapy as a distinct subspecialty within the wider discipline of yoga practice;
    Increase mainstream awareness of the holistic value and impact of Yoga Therapy; and
    Drive the adoption of Yoga Therapy in diverse industries and settings in both public and private sectors.

Advisory - Only use authorized nicotine pouches as directed, and do not use unauthorized nicotine pouches

Retrieved on: 
Wednesday, March 20, 2024
Palpitations, Varenicline, Chest pain, Xerostomia, Dizziness, Weakness, Caregiver, Nervous, Indigestion, Sleep, Risk, Headache, NPN, Health, Nicotine, Angina, Internet, Stroke, Constipation, Smoke, Death, Heartburn, Health Canada, Arrhythmia, Nausea, Medicine, Nursing, Safety, Fatigue, Vomiting, Blurred vision, Allergy, Parent, Chronic pain, Advertising, Tobacco

Consuming multiple nicotine products at the same time, including authorized nicotine replacement therapy products, or varenicline (a prescription smoking cessation drug), may increase the adverse effects of nicotine.

Key Points: 
  • Consuming multiple nicotine products at the same time, including authorized nicotine replacement therapy products, or varenicline (a prescription smoking cessation drug), may increase the adverse effects of nicotine.
  • Use authorized nicotine pouches only as directed:
    To date, Health Canada has authorized only one nicotine pouch , containing 4 mg of nicotine per dose.
  • Nicotine replacement therapies, including nicotine pouches, are not authorized for recreational use or for use by nonsmokers and people under 18 years old.
  • There are no authorized nicotine pouches in Canada that contain more than 4 mg of nicotine per dose.